Eikon Therapeutics’ lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7/8 agonist, the biotech is also developing PARP inhibitors that could have advantages over cancer drugs currently available from this class. The post Eikon Raises $350M for Cancer Drug Pipeline Led by…
As Congress considers ways to cut Medicaid spending to help finance the extension of federal tax cuts, a new KFF analysis finds that imposing a cap on federal spending per Medicaid enrollee—known as a “per capita cap”—could trigger a decrease in federal Medicaid spending over a 10-year period of $532 billion to almost $1 trillion,…More
This analysis examines the potential impacts on states, Medicaid enrollees, and providers of implementing a per capita cap on federal Medicaid spending, which is one proposal that has been discussed in Congress. Such a plan could decrease federal Medicaid spending by $532 billion to almost $1 trillion over a 10-year period, depending on how states…
From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out The post Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time appeared first on…
For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity. The post The Role of Medication Delivery in Non-Adherence appeared first on MedCity News.
El vestíbulo de la clínica comunitaria St. John’s Community Health en el sur de Los Ángeles está repleto de pacientes, pero a la trabajadora de salud comunitaria Ana Ruth Varela le preocupa que todo se vuelva mucho más tranquilo. Dijo que muchos pacientes tienen miedo de salir de sus casas. “El otro día hablé con…
ALTADENA, Calif. — As flames engulfed a nearby canyon, dozens of residents in a sober-living home fled to an unoccupied building about 30 miles south. The evacuees, many of whom were previously homeless, watched helplessly as their home burned on live TV. When they awoke on air mattresses the next morning, loss set in. Some…
The lobby at this St. John’s Community Health clinic in South Los Angeles bustles with patients. But community health worker Ana Ruth Varela is worried that it’s about to get a lot quieter. Many patients, she said, are afraid to leave their homes. “The other day I spoke with one of the patients. She said:…
By KIM BELLARD Many people don’t realize it, but a hundred years ago America was something of a scientific backwater. Oh, sure, we had the occasional Nobel laureate, but the center of science was in Europe, particularly Germany. Then in the early 1930’s the Nazis decided that “purity” – of political ideas, of blood –…
A friend of mine who wants to stay anonymous (for now at any rate) had a crazy waste of time proving that he was eligibile for a medication on his plan. I thought his story might trigger a few of you! And yes Optum is of course part of United HealthGroup–Matthew Holt Here is the…